Menu
Back to Journals » Drug, Healthcare and Patient Safety » Volume 7
Original Research
Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 15,650 | Dovepress* | 13,981+ | 1,435 | 15,416 | |
| PubMed Central* | 1,669 | 309 | 1,978 | ||
| Totals | 15,650 | 1,744 | 17,394 | ||
|
*Since 15 December 2015 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 18 | 0 | 0 | 0 | 8 | 10 |
View citations on PubMed Central and Google Scholar